ACTG Protocol A5269 The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naïve Genotype 1 Subjects with HIV Coinfection

Grant

Date/time Interval

  • March 14, 2011 - May 31, 2013

    • Awarded By

    Total Award Amount

  • 56688.00

    • Direct Costs

  • 38695.00

    • Sponsor Award Id

  • CRB-APHRM-S-10-00170

    • Contributor

  • Victoria Johnson   Principal Investigator